All lobbying filings

FEDERAL HEALTH COUNSEL, LLC

FEDERAL HEALTH COUNSEL, LLC filed a Q2 report for AMGEN, INC. on July 20, 2025.

Lobbying for AMGEN, INC. · Pharmaceutical Company

All filings by FEDERAL HEALTH COUNSEL, LLC · Everything AMGEN, INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 20, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Official filing document

Lobbying activity 1

Medicare/Medicaid

Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid Rebate and Best Price. issues relating to MFN pricing and other price controls in drugs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.